Close Menu

A Reuters story looks into sequencing and health research, particularly focusing on the UK Biobank, a project that aims to enroll 500,000 people to have their DNA sequenced and their health tracked over time. The biobank investigators hope to find rare variants linked to common diseases, building on the work of others, including Decode. Another area of particular interest for sequencing technologies, the article continues, is cancer.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Imperial College London researchers are shifting away from testing a COVID-19 vaccine to focus on combating newly emerging SARS-CoV-2 variants, the Independent says.

According to the Associated Press, genetic genealogy has helped law enforcement officials identify an unknown victim of the Green River Killer.

In PNAS this week: target to reduce chemotherapy-induced cardiac injury, tool finds ancient endogenous RNA viruses, and more.

Moderna reports its vaccine is effective against new SARS-CoV-2 strains, though it is also developing a booster, according to the New York Times.